Tenaya Therapeutics, Inc. (TNYA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -19.23M | -13.94M | -15.6M | -15.61M | -23.11M | -18.39M | -19.84M | -23.62M | -28.66M | -21.92M | -23.64M | -26.22M | -30.29M | -22.68M | -27.56M | -25.43M | -28.76M | -16.35M | -16.66M | -12.02M |
| Operating CF Margin % | -8548.44% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 16.78% | 24.19% | 21.36% | 33.89% | 19.36% | 16.13% | 16.08% | 9.93% | 5.38% | 3.34% | 14.22% | -3.11% | -5.33% | -38.75% | -65.43% | -111.58% | -82.13% | -57.17% | - | - |
| Net Income | -19.27M | -20.18M | -20.27M | -23.28M | -26.86M | -23.84M | -25.63M | -29.43M | -32.23M | -29.93M | -29.14M | -33.27M | -31.74M | -33.52M | -30.7M | -28.4M | -31.06M | -26.15M | -18.26M | -15.21M |
| Depreciation & Amortization | 1.76M | 1.8M | 1.86M | 2.38M | 2.66M | 2.09M | 2.1M | 2.12M | 2.15M | 2.99M | 2.18M | 2.19M | 2.13M | 2.12M | 2.8M | 1.76M | 1.3M | 791K | 1.05M | 735K |
| Stock-Based Compensation | 0 | 2.75M | 2.93M | 3.64M | 3.73M | 3.76M | 3.91M | 4.61M | 4.22M | 0 | 4.01M | 3.83M | 3.51M | 3.19M | 0 | 0 | 0 | 1.05M | 0 | 502K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -315K | -489K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.86M | 801K | 799K | 643K | 795K | 636K | 1.11M | 1.02M | 828K | 5.7M | 848K | 829K | 239K | 543K | 3M | 3.15M | 2.24M | 503K | 978K | 263K |
| Working Capital Changes | -4.58M | 893K | -921K | 1.01M | -3.44M | -1.04M | -1.32M | -1.94M | -3.64M | -671K | -1.22M | 683K | -4.44M | 4.99M | -2.66M | -1.94M | -1.24M | 7.46M | -428K | 1.69M |
| Change in Receivables | -10.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.46M | 531K | -447K | -1.14M | -379K | -701K | 1.28M | -2.43M | 1.27M | -305K | -2.75M | 1.1M | -1.32M | 3.46M | 317K | -341K | -1.78M | 6.08M | 1.16M | 745K |
| Cash from Investing | -11K | -67K | 8.86M | 24.99M | 22.3M | 14.1M | -30.1M | 21.61M | -4.49M | -14.92M | 30.49M | 25.09M | 8.06M | 5.97M | 31.03M | 30.21M | 16.43M | -62.58M | -168.43M | -3.24M |
| Capital Expenditures | -11K | -67K | -26K | -142K | -383K | -204K | -184K | -73K | -564K | -394K | -8K | -208K | -629K | -795K | -4.06M | -7.18M | -8.6M | -12.55M | -5.01M | -3.24M |
| CapEx % of Revenue | 4.89% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 12K | 4K | 1K | -18K | -4K | 9K | -12K | 8K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -415K | 58.24M | 380K | -476K | 50.26M | 377K | 31K | 570K | 46.77M | 371K | 0 | 4.18M | -501K | 77.49M | 6K | 260K | 15K | -21K | 190.27M | -1.3M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 58.24M | 380K | -476K | 50.26M | 0 | 31K | 0 | 46.76M | 371K | 0 | 3.87M | 0 | 77.39M | 6K | 260K | 15K | -64K | 190.27M | -5K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3K | 0 |
| Other Financing | -415K | 0 | 0 | 0 | 0 | 377K | 0 | 570K | 9K | 0 | 0 | 311K | -501K | 99K | 0 | 0 | 0 | 43K | 0 | -1.29M |
| Net Change in Cash | -19.66M | 44.23M | -6.36M | 8.9M | 49.45M | -3.91M | -49.9M | -1.43M | 13.62M | -36.47M | 6.85M | 3.04M | -22.73M | 60.78M | 3.48M | 5.04M | -12.16M | -78.95M | 5.19M | -16.55M |
| Free Cash Flow | -19.25M | -14.01M | -15.63M | -15.76M | -23.5M | -18.59M | -20.02M | -23.69M | -29.22M | -22.32M | -23.65M | -26.43M | -30.92M | -23.48M | -31.62M | -32.61M | -37.35M | -28.9M | -21.66M | -15.26M |
| FCF Margin % | -8553.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 18.09% | 24.66% | 21.95% | 33.5% | 19.6% | 16.7% | 15.33% | 10.36% | 5.48% | 4.94% | 25.22% | 18.95% | 17.22% | 18.77% | -45.95% | -113.74% | -85.72% | -55.57% | - | - |
| FCF per Share | -0.13 | -0.09 | -0.10 | -0.10 | -0.21 | -0.22 | -0.23 | -0.28 | -0.36 | -0.33 | -0.32 | -0.36 | -0.42 | -0.42 | -0.76 | -0.79 | -0.91 | -0.70 | -0.81 | -0.41 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.69x | 0.77x | 0.67x | 0.86x | 0.77x | 0.77x | 0.80x | 0.89x | 0.73x | 0.81x | 0.79x | 0.95x | 0.68x | 0.90x | 0.90x | 0.93x | 0.63x | 0.91x | 0.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |